Argatroban Monohydrate

References

• Comparative study on heparin and a synthetic thrombin inhibitor no. 805 (MD-805*) in experimental antithrombin III-deficient animals
  • T. Kumada, Y. Abiko, Thromb. Res. 1981, 24, 285.
• Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion
  • S. Okamoto, A. Hijikata, R. Kikumoto, S. Tonomura, H. Hara, K. Ninomiya, A. Maruyama, M. Sugano, Y. Tamao, Biochem. Biophys. Res. Commun. 1981, 101, 440.
• Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N²-[1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acid
  • R. Kikumoto, Y. Tamao, T. Tezuka, S. Tonomura, H. Hara, K. Ninomiya, A. Hijikata, S. Okamoto, Biochemistry 1984, 23, 85.
• Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time
  • C. N. Berry, D. Girard, S. Lochot, C. Lecoffre, Br. J. Pharmacol. 1994, 113, 1209.
• Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.
  • H. Kawai, S. Yuki, J. Sugimoto, Y. Tamao, J. Pharmacol. Exp. Ther. 1996, 278, 780.
• Argatroban (a review)
  • K. McKeage, G. L. Plosker, Drugs 2001, 61, 515.
• Direct thrombin inhibitors in acute coronary syndromes: present and future (a review)
  • J. I. Weitz, H. R. Buller, Circulation 2002, 105, 1004.
• Argatroban: Update (a review)
  • R. W. Yeh, I.-K. Jang, Am. Heart J. 2006, 151, 1131.